|Bid||6.80 x 1200|
|Ask||6.83 x 1800|
|Day's range||6.76 - 7.01|
|52-week range||3.50 - 24.90|
|Beta (5Y monthly)||0.51|
|PE ratio (TTM)||N/A|
|Earnings date||10 Nov 2021 - 15 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Nov 2012|
|1y target est||12.50|
SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Tyson Foods, Inc., Vaxart, Inc., Apyx Medical Corporation, and eHealth, Inc. If you are a current owner of shares of any of these stocks, contact firstname.lastname@example.org or call (619) 708-3993. Tyson Foods, Inc. (NYSE: TSN) Shareholder Rights Investigation Morris Kandinov is investigating Tyson Foods, Inc. regarding corporate governance failures, possible bre
There are a handful of companies that dominate the coronavirus vaccine market. Vaccine hesitancy prevents many people from getting inoculated. One company looking to make headway into the vaccine-hesitant crowd is Vaxart (NASDAQ: VXRT).
Vaxart (NASDAQ: VXRT) soared to stardom when its shares advanced 1,500% last year. The biotech company is developing a coronavirus-vaccine candidate in pill form. With 56% of Americans fully vaccinated, though, your question now may: Will Vaxart be too late to carve out market share?